Artificial intelligence (AI) and machine learning (ML) are revolutionizing the pharmaceutical industry, particularly in drug development and delivery. These technologies enable precision medicine by analyzing extensive datasets to optimize formulations and predict patient responses. AI-driven models enhance nanoparticle-based drug carriers, improving their stability, bioavailability, and targeting accuracy. ML also facilitates real-time monitoring and adaptive control of drug release, ensuring better therapeutic outcomes. This review explores the integration of AI and ML in drug delivery, highlighting their potential to accelerate development, reduce costs, and advance personalized medicine.